iHuman Statistics
Total Valuation
iHuman has a market cap or net worth of $91.97 million. The enterprise value is -$64.84 million.
Important Dates
The last earnings date was Monday, December 29, 2025, before market open.
| Earnings Date | Dec 29, 2025 |
| Ex-Dividend Date | Apr 17, 2025 |
Share Statistics
iHuman has 51.10 million shares outstanding. The number of shares has decreased by -1.38% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 51.10M |
| Shares Change (YoY) | -1.38% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 72.02% |
| Owned by Institutions (%) | 0.33% |
| Float | 14.30M |
Valuation Ratios
The trailing PE ratio is 6.57.
| PE Ratio | 6.57 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| Forward PS | n/a |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.46 |
| Quick Ratio | 3.18 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.15% and return on invested capital (ROIC) is 4.72%.
| Return on Equity (ROE) | 11.15% |
| Return on Assets (ROA) | 3.26% |
| Return on Invested Capital (ROIC) | 4.72% |
| Return on Capital Employed (ROCE) | 7.32% |
| Revenue Per Employee | $164,954 |
| Profits Per Employee | $20,686 |
| Employee Count | 723 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 14.60 |
Taxes
In the past 12 months, iHuman has paid $917,940 in taxes.
| Income Tax | 917,940 |
| Effective Tax Rate | 5.78% |
Stock Price Statistics
The stock price has increased by +7.78% in the last 52 weeks. The beta is 0.04, so iHuman's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +7.78% |
| 50-Day Moving Average | 2.37 |
| 200-Day Moving Average | 2.52 |
| Relative Strength Index (RSI) | 23.99 |
| Average Volume (20 Days) | 14,216 |
Short Selling Information
| Short Interest | 3,198 |
| Short Previous Month | 1,220 |
| Short % of Shares Out | 0.02% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.33 |
Income Statement
In the last 12 months, iHuman had revenue of $119.26 million and earned $14.96 million in profits. Earnings per share was $0.27.
| Revenue | 119.26M |
| Gross Profit | 80.99M |
| Operating Income | 10.21M |
| Pretax Income | 15.87M |
| Net Income | 14.96M |
| EBITDA | 12.33M |
| EBIT | 10.21M |
| Earnings Per Share (EPS) | $0.27 |
Full Income Statement Balance Sheet
The company has $158.47 million in cash and $1.65 million in debt, with a net cash position of $156.81 million or $3.07 per share.
| Cash & Cash Equivalents | 158.47M |
| Total Debt | 1.65M |
| Net Cash | 156.81M |
| Net Cash Per Share | $3.07 |
| Equity (Book Value) | 138.11M |
| Book Value Per Share | 2.70 |
| Working Capital | 129.70M |
Full Balance Sheet Margins
Gross margin is 67.91%, with operating and profit margins of 8.56% and 12.54%.
| Gross Margin | 67.91% |
| Operating Margin | 8.56% |
| Pretax Margin | 13.31% |
| Profit Margin | 12.54% |
| EBITDA Margin | 10.34% |
| EBIT Margin | 8.56% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.09, which amounts to a dividend yield of 4.72%.
| Dividend Per Share | $0.09 |
| Dividend Yield | 4.72% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 31.04% |
| Buyback Yield | 1.38% |
| Shareholder Yield | 6.10% |
| Earnings Yield | 16.26% |
| FCF Yield | n/a |
Dividend Details Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
iHuman has an Altman Z-Score of 2.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.94 |
| Piotroski F-Score | 3 |